{"id":"https://openalex.org/A5113881172","orcid":null,"observed_orcids":[],"display_name":"G. Griffiths","raw_author_names":["G. Griffiths","Gary Griffiths"],"full_name":"G. W. G. GRIFFITHS","works_count":15,"cited_by_count":520,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":6,"i10_index":6},"ids":{"openalex":"https://openalex.org/A5113881172","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210147479","ror":"https://ror.org/04j971w37","display_name":"Cyclacel Pharmaceuticals (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210147479"]},"years":[2010,2004,2003]},{"institution":{"id":"https://openalex.org/I98677209","ror":"https://ror.org/01nrxwf90","display_name":"University of Edinburgh","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]},"years":[2004]}],"last_known_institutions":[{"id":"https://openalex.org/I4210147479","ror":"https://ror.org/04j971w37","display_name":"Cyclacel Pharmaceuticals (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210147479"]}],"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","count":12,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","count":7,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","count":5,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","count":4,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","count":4,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","value":4.67e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12318","display_name":"Quinazolinone synthesis and applications","value":4.41e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","value":3.68e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","value":3.21e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","value":1.96e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.9190388917922974},{"id":"184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","score":0.6924912929534912},{"id":"71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","score":0.6187732219696045},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.5525741577148438},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.4717805087566376}],"counts_by_year":[{"year":2003,"works_count":8,"oa_works_count":1,"cited_by_count":0},{"year":2004,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":2010,"works_count":5,"oa_works_count":1,"cited_by_count":0},{"year":2012,"works_count":0,"oa_works_count":0,"cited_by_count":33},{"year":2013,"works_count":0,"oa_works_count":0,"cited_by_count":32},{"year":2014,"works_count":0,"oa_works_count":0,"cited_by_count":27},{"year":2015,"works_count":0,"oa_works_count":0,"cited_by_count":32},{"year":2016,"works_count":0,"oa_works_count":0,"cited_by_count":35},{"year":2017,"works_count":0,"oa_works_count":0,"cited_by_count":24},{"year":2018,"works_count":0,"oa_works_count":0,"cited_by_count":27},{"year":2019,"works_count":0,"oa_works_count":0,"cited_by_count":25},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":26},{"year":2021,"works_count":0,"oa_works_count":0,"cited_by_count":27},{"year":2022,"works_count":0,"oa_works_count":0,"cited_by_count":18},{"year":2023,"works_count":0,"oa_works_count":0,"cited_by_count":21},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":13},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":21},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":12}],"display_name_alternatives":["G. Griffiths","Gary Griffiths"],"block_key":"g griffiths","works_api_url":"https://api.openalex.org/works?filter=author.id:A5113881172","updated_date":"2026-11-04T11:47:51","created_date":"2016-06-24T00:00:00"}